Combating the Coronavirus Pandemic
Applied DNA completed the design of a diagnostic kit for SARS-COV-2 (the virus that causes the disease COVID-19) for distribution under FDA Emergency Use Authorization.
Our patented and proprietary platform for the production of linear DNA empowers rapid development and large-scale production that we believe will yield a safe and effective vaccine with fewer risks than other DNA production platforms. To date, Applied DNA and Takis Biotech have designed 5 preclinical vaccine candidates.
Applied DNA/Takis received approval from Italy’s Ministry of Health to begin a preclinical trial of one of their COVID-19 vaccine candidates.
Hear from our partners and customers
TEXTILES & APPAREL
“Applied DNA’s CertainT platform
provides customers and brands
with the highest level of trust
in terms of the authenticity
of their products.”
“SigNature molecular tags and authentication technologies provide value-addition at a time when regulators are demanding that the industry implement serialization in order to track packaging.”
“We believe that is the advantage
that Applied DNA’s platform
affords us over traditional
vaccine development and
other modern DNA-based vaccines.”
Dr. Luigi Aurisicchio
CEO and CSO of Takis Biotech
Applied DNA is…
using biotechnology as a forensic foundation, to create unique security solutions that address the challenges of modern commerce. Whether working in supply chain security, brand protection or law enforcement applications, our goal is to help establish secure and flourishing environments that foster quality, integrity and success.
SigNature® DNA resists wash off, even in aggressive industrial treatment baths. Results are not obscured by false positives. We are not afraid to be tested in court. We are not just a warning sticker on a door: SigNature DNA technology enforces deterrent value with real, proven results.